• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

drug targets

Research

How Amgen, AZ's Tezspire holds promise for colorectal cancer

Scientists at the Benaroya Research Institute identified a subset of Treg cells that appear to fuel the development of colorectal cancer.
Angus Liu May 18, 2022 2:00pm

Insilico's target discovery AI zeroes in on age-related diseases

Mar 29, 2022 3:55pm

Omega taps Stanford to find targets for genome-tuning tech

Oct 14, 2021 9:05am

Glioblastoma map points to new drug targets and I-O approaches

Feb 11, 2021 11:00am

Outsmarting an 'undruggable' cancer-driving gene

Feb 1, 2021 8:30am

Boehringer inks Enara deal to source oncology 'dark antigens'

Jan 12, 2021 7:45am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy